Shelton Capital Management’s NeoGenomics NEO Stock Holding History

Shelton Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,328	Closed	-$250K	–	855
2021 Q4	$250K	Hold	7,328	–	–	0.01%	664
2021 Q3	$354K	Hold	7,328	–	–	0.01%	483
2021 Q2	$331K	Hold	7,328	–	–	0.01%	527
2021 Q1	$353K	Sell	7,328 -150	-2%	-$7.81K	0.01%	487
2020 Q4	$403K	Hold	7,478	–	–	0.02%	399
2020 Q3	$276K	Hold	7,478	–	–	0.01%	573
2020 Q2	$232K	Sell	7,478 -1,145	-13%	-$31.7K	0.01%	536
2020 Q1	$238K	Sell	8,623 -437	-5%	-$13.1K	0.02%	477
2019 Q4	$265K	Buy	+9,060	New	+$216K	0.01%	596

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Shelton Capital Management's NEO Position: Q1 2022 in Review

Shelton Capital Management sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 7,328 shares — an estimated $250K sold.

Shelton Capital Management first reported a position in NEO in Q4 2019 and held it in 9 quarters. The position peaked at $403K in Q4 2020. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

Shelton Capital Management reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
Shelton Capital Management sold 7,328 NeoGenomics shares in Q1 2022, an estimated $250K.
Shelton Capital Management first reported a position in NeoGenomics in Q4 2019 and held it in 9 quarters.
Shelton Capital Management's NeoGenomics position peaked at $403K in Q4 2020.
279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Shelton Capital Management's 13F filing for Q1 2022, filed 12 May 2022.